2022 World Conference on Lung Cancer (ePosters)-EP02.03-023. Decreasing Time to Definitive Therapy with MIDAS: Minimally Invasive Diagnosis and Surgery

Pdf Summary

The study evaluated the safety and efficacy of combining minimally invasive diagnosis and surgery (MIDAS) during a single anesthesia episode for patients with lung nodules. The approach involved using robotic navigational bronchoscopy to access and biopsy nodules in the lung periphery, followed by surgical resection using the da Vinci Xi robot or VATS. The study found that MIDAS was safe and well-received by patients, with 97% opting to have the procedure. It did not add any morbidity or complications to the hospital stay. <br /><br />The main benefit of MIDAS is the reduction in the time between nodule diagnosis and definitive treatment, which could lead to better survival outcomes by shifting the resection to an earlier stage. The ability to reach, diagnose, localize, and resect small lesions in a compressed timeline may also contribute to enhanced long-term outcomes for patients. Additionally, MIDAS maximizes pulmonary parenchymal sparing procedures and reduces the risks associated with multiple procedures and anesthesia.<br /><br />From a patient perspective, MIDAS eliminates the anxiety-inducing period between diagnosis and resection, providing a more comprehensive plan for management and enhancing patient satisfaction. For providers, this approach increases the likelihood of maintaining a minimally invasive surgical approach and allows for program growth in thoracic oncology. <br /><br />Furthermore, implementing MIDAS can lead to lower total costs of care by decreasing the impact on family resources and allowing patients to return to employment and their usual lifestyle earlier. <br /><br />In terms of patient characteristics, the study included a range of ages (34-88), with an average age of 71.1. Females made up a larger proportion of the study population (54 out of 75 patients). The mean nodule size was 14mm. Indocyanine Green (ICG) with Firefly illumination was used during robotic resections to aid in localization. The majority of the robotic resections were lobectomies (29 out of 75 cases). <br /><br />Overall, the study suggests that MIDAS may be a promising approach for the management of lung nodules, providing faster definitive therapy and potential improvements in patient outcomes.

Asset Subtitle

Patrick Ross

Meta Tag

Speaker Patrick Ross

Topic Early Stage Non-small Cell Lung Cancer - Surgery

Keywords

MIDAS

minimally invasive diagnosis and surgery

lung nodules

robotic navigational bronchoscopy

da Vinci Xi robot

VATS

safety and efficacy

reduction in time

pulmonary parenchymal sparing procedures

patient satisfaction